Mature startup, immature leadership - Anonymous Employee sorcero Employee Review

1.0
Apr 9, 2026
Recommend
CEO approval
Business Outlook

Pros

Sorcero operates in an interesting space with real market need. There are intelligent, hardworking people here. Unfortunately, the most capable ones recognize the fundamental issues and are planning their exits.

Cons

Sorcero is a company where the branding is far more developed than the business itself. Externally it looks sophisticated and strategic. Internally it feels chaotic, immature and badly run. Significant effort goes into jargon and self congratulations, but there is not enough substance underneath. The biggest issue is leadership. The C-suite seems far more interested in appearing impressive than building a company that functions properly. Ego and optics drive too much of the decision-making. Priorities shift constantly, accountability is nonexistent and employees are expected to deliver excellent work in dysfunctional conditions. Roles are poorly defined, workloads excessive, boundaries weak. Structural problems do not get fixed. They get pushed down until employees absorb them. When things go well, leadership takes credit. When things go badly, the burden lands on staff. The result is exhausting, demoralizing, and toxic. What is especially concerning is how this gets brushed off as “startup culture” or “moving fast”. For a mature startup, that excuse does not hold. Despite the denials and finger pointing, this is a serious leadership problem. In a company operating in life sciences, where work touches healthcare, the lack of rigor is alarming. When leadership treat honesty, accountability and discipline as nice to haves, everyone should be worried.

Explore other reviews about sorcero

5.0
Mar 6, 2026
Recommend
CEO approval
Business Outlook

Pros

Product is impactful to patients and winning in market; innovative culture and team. Big logos/customers. Strong R&D culture.

Cons

Long hours and lots of travel. Low pay compared to larger AI firms. DC location 2nd tier for pharma tech. Invest in Finance/Ops.

1.0
Jul 21, 2026
Recommend
CEO approval
Business Outlook

Pros

The team members still showed up. • Formal requests for essential tools disappeared into an approval process that never ended • Those in charge blamed budget constraints while continuing to hire more staff • Half my time was spent creating systems that should have already been in place • Every report suffered because of missing resources • Work came to a standstill whenever specialized tools were required

Cons

• Equipment and infrastructure needed to do the work simply did not exist

See reviews by: Helpful|Rating|Date|All